Cargando…
Bone‐Targeted Delivery of Cell‐Penetrating‐RUNX2 Fusion Protein in Osteoporosis Model
The onset of osteoporosis leads to a gradual decrease in bone density due to an imbalance between bone formation and resorption. To achieve optimal drug efficacy with minimal side effects, targeted drug delivery to the bone is necessary. Previous studies have utilized peptides that bind to hydroxyap...
Autores principales: | Kim, Seoyeon, Lee, Haein, Hong, Jiyeon, Kim, Seung Hyun L., Kwon, Euntaek, Park, Tai Hyun, Hwang, Nathaniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558633/ https://www.ncbi.nlm.nih.gov/pubmed/37574255 http://dx.doi.org/10.1002/advs.202301570 |
Ejemplares similares
-
Cellular direct conversion by cell penetrable OCT4-30Kc19 protein and BMP4 growth factor
por: Kim, Seung Hyun L., et al.
Publicado: (2022) -
RUNX2-modifying enzymes: therapeutic targets for bone diseases
por: Kim, Woo-Jin, et al.
Publicado: (2020) -
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019) -
First Case of ETV6–RUNX1 Fusion in Adult De Novo Acute Myeloid Leukemia Detected Using Targeted RNA Sequencing
por: Jeon, Seong-Jun, et al.
Publicado: (2023) -
CT and MR for bone mineral density and trabecular bone score assessment in osteoporosis evaluation
por: Lee, Haein, et al.
Publicado: (2023)